SESTINA BIO USES INSCRIPTA’S ONYX® PLATFORM TO DEVELOP MICROBIAL STRAIN READY FOR SCALE-UP IN LESS THAN 12 MONTHS

Inscripta and Sestina Bio announced successful development of a ready-to-scale microbial strain producing Bakuchiol, a natural retinol replacement. PLEASANTON, Calif., Oct. 5, 2022 /PRNewswire/ — Inscripta, Inc., a global leader in automated, CRISPR-based gene editing technology, and…